About Epithalon/Epitalon - Anti-Aging Longevity Peptide

Epithalon is a pineal peptide best known for stimulating telomerase activity, which helps protect and lengthen telomeres to slow down cellular aging. It also helps regulate your circadian rhythm and natural melatonin production, promoting deeper sleep and systemic longevity.

WHAT THE RESEARCH SHOWS

Epithalon (also known as Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Prof. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It was engineered to mimic Epithalamin, a natural peptide extract from the pineal gland, and is one of the most extensively researched longevity peptides in the world. Here is what the published research shows:
* Telomerase Activation & Telomere Elongation:
* Epithalon's most famous mechanism is its ability to upregulate telomerase reverse transcriptase (TERT) activity. In human cell cultures (fibroblasts), research showed it extended telomere length and allowed cells to surpass the "Hayflick limit" (the natural cap on cellular division), enabling up to 10 extra cell divisions without oncogenic mutations.
* Restoration of Melatonin & Circadian Rhythms:
* As the pineal gland calcifies and ages, nighttime melatonin production drops dramatically. Clinical trials in elderly humans demonstrated that Epithalon restores nocturnal melatonin synthesis back toward youthful levels, normalizing sleep patterns, neuroendocrine function, and biological clocks.
* Reduction in All-Cause Mortality (Long-Term Human Trials): * In landmark 6- to 12-year clinical follow-up studies on elderly patients (ages 60-90), patients receiving periodic courses of pineal peptides experienced a significantly lower mortality rate (up to a 28–50% reduction in all-cause mortality) compared to control groups, largely driven by improved cardiovascular health and immune resistance. * Tumor Suppression & Antioxidant Defense:
* In long-term rodent studies, Epithalon significantly reduced the incidence of spontaneous tumors and chromosomal aberrations. It also ramped up the body's primary antioxidant defenses by boosting levels of superoxide dismutase (SOD) and glutathione peroxidase while lowering lipid peroxidation.
* The Research Context:
* The vast majority of peer-reviewed clinical research on Epithalon was conducted across several decades in Russia. While Western clinical trials are sparse, the Russian gerontology data across both animal models and human cohorts is unusually extensive for a peptide.
The Bottom Line:
Epithalon is primarily studied as a cellular longevity and biological reset tool rather than an acute fix. Because of its gene-expression and telomerase effects, researchers typically study it in short, periodic cycles (such as 10 to 20 days, once or twice a year) rather than as a continuous, year-round daily peptide.

STUDIES

• Telomerase activation in human cells. The foundational 2003 study by Khavinson, Bondarev and Butyugov found that Epithalon reactivated telomerase in human fetal fibroblasts that had none, induced hTERT expression and lengthened telomeres. This is the core claim. drpattaylor - LINK
• Independent replication (2025). This is the most important recent development. Al-Dulaimi, Thomas and colleagues at Brunel University London treated normal human mammary epithelial cells and fibroblasts with Epitalon, and reported telomere lengthening that increased with dose, via hTERT and telomerase upregulation. As a UK result, it’s especially useful for your audience. superpowersuperpower - LINK
• Reproductive cell research (2025, South Korea). In bovine egg cells, Epitalon activated telomerase, improved maturation rate, and enhanced blastocyst hatching and implantation potential after thawing. superpower - LINK
• Melatonin and antioxidant effects. In preclinical and aged primate studies, Epitalon activated telomerase, restored pineal melatonin production, and enhanced antioxidant activity. preprints - LINK

Lyophilised powder